Nakakuki Masanori, Kawano Hiroyuki, Notsu Tatsuto, Imada Kazunori, Mizuguchi Kiyoshi, Shimano Hitoshi
Development Research, Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd., 722 Jimba-aza-Uenohara, Gotemba, Shizuoka 412-8524; and Department of Internal Medicine (Endocrinology and Metabolism), Graduate School of Comprehensive Human Sciences, Faculty of Medicine, and International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
J Biochem. 2014 May;155(5):301-13. doi: 10.1093/jb/mvu019. Epub 2014 Apr 11.
The proteolytic cascade is the key step in transactivation of sterol regulatory element-binding proteins (SREBPs), a transcriptional factor of lipid synthesis. Proteolysis of SREBP-2 is strictly regulated by sterols, but that of SREBP-1c was not strongly sterol-regulated, but inhibited by polyunsaturated fatty acids (PUFAs). In this study, the proteolytic processing of SREBP-1 and -2 was examined by transfection studies of cDNA-encoding mutants in which all the known cleavage sites were disrupted. In cultured cells, sterol-regulated SREBP-2 processing was completely eliminated by mutation of cleavage sites. In contrast, the corresponding SREBP-1c mutants as well as wild type exhibited large amounts of cleaved products in the nuclear extracts from culture cells and murine liver in vivo. The nuclear form of the mutant SREBP-1c was induced by delipidated condition and suppressed by eicosapentaenoic acid, an n-3 PUFA, but not by sterols. This novel processing mechanism was affected by neither SREBP cleavage-activating protein (SCAP) nor insulin-induced gene (Insig)-1, unlike SREBP-2, but abolished by a serine protease inhibitor. Through analysis of deletion mutant, a site-2 protease recognition sequence (DRSR) was identified to be involved in this novel processing. These findings suggest that SREBP-1c cleavage could be subjected to a novel PUFA-regulated cleavage system in addition to the sterol-regulatory SCAP/Insig system.
蛋白水解级联反应是固醇调节元件结合蛋白(SREBPs)转录激活的关键步骤,SREBPs是脂质合成的转录因子。SREBP-2的蛋白水解受到固醇的严格调控,但SREBP-1c的蛋白水解不受固醇强烈调控,而是受到多不饱和脂肪酸(PUFAs)的抑制。在本研究中,通过对编码所有已知切割位点均被破坏的突变体的cDNA进行转染研究,检测了SREBP-1和-2的蛋白水解过程。在培养细胞中,切割位点的突变完全消除了固醇调节的SREBP-2加工过程。相反,相应的SREBP-1c突变体以及野生型在培养细胞和小鼠肝脏体内的核提取物中均表现出大量的切割产物。突变型SREBP-1c的核形式在脱脂条件下被诱导,并被n-3多不饱和脂肪酸二十碳五烯酸抑制,但不受固醇抑制。与SREBP-2不同,这种新的加工机制既不受SREBP切割激活蛋白(SCAP)的影响,也不受胰岛素诱导基因(Insig)-1的影响,但被丝氨酸蛋白酶抑制剂消除。通过对缺失突变体的分析,确定了一个2位点蛋白酶识别序列(DRSR)参与了这种新的加工过程。这些发现表明,除了固醇调节的SCAP/Insig系统外,SREBP-1c的切割可能还受到一种新的PUFA调节的切割系统的作用。